Jean-Marc Limacher

Jean-Marc Limacher

Company: Odimma therapeutics

Job title: Co-Founder, President & Chief Medical Officer


Clinical Trial Design Showing Vaccine-Induced Clinical Efficacy 2:00 pm

Discussing the current methods of testing immunogenicity Expanding the focus to testing clinical outcomes Demonstrating clinical benefits of neoantigens by controlled group clinical trial      Read more

day: Track B - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.